Effects of PKF 115–584 on cell migration and invasion.

Lab / animal OA: green CC0
⚙ AI-generated deep summary by qwen3.7-flash, 2026-09-15 · read from full text ⓘ

This study investigated the in vitro effects of PKF 115–584, a small-molecule antagonist of the Tcf/ß-Catenin complex, on cell migration and invasion. The researchers compared endometrial epithelial and stromal cells from patients with endometriosis against those from patients without the condition across different menstrual phases. Results indicated that treatment with PKF 115–584 significantly reduced the number of migrated and invasive cells in both epithelial and stromal populations. This paper is centrally about endometriosis — specifically examining how inhibiting the Wnt signaling pathway affects the migratory and invasive potential of endometrial cells in this disease context.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

A, B: Number of migrated cells/mm2 in non-treated and PKF 115–584–treated endometrial epithelial (A) and stromal (B) cells of patients with and without endometriosis. C, D: Number of invasive cells/mm2 in non-treated and PKF 115–584–treated endometrial epithelial (C) and stromal (D) cells of patients with and without endometriosis. Results are presented as the mean+SEM. M: menstrual phase, P: proliferative phase, S: secretory phase. Endo (+): Endometrium of patients with endometriosis (M: n = 4, P: n = 8, S: n = 8). Endo (–): endometrium of patients without endometriosis (M: n = 4, P: n = 5, S: n = 5). a: p<.05 versus PKF 115–584–treated endometrial epithelial or stromal cells of patients without endometriosis.
Full text 931 characters · extracted from oa-doi-fallback · click to expand
In Vitro Effects of a Small-Molecule Antagonist of the Tcf/ß-Catenin Complex on Endometrial and Endometriotic Cells of Patients with Endometriosis Figure 2 Effects of PKF 115–584 on cell migration and invasion. A, B: Number of migrated cells/mm2 in non-treated and PKF 115–584–treated endometrial epithelial (A) and stromal (B) cells of patients with and without endometriosis. C, D: Number of invasive cells/mm2 in non-treated and PKF 115–584–treated endometrial epithelial (C) and stromal (D) cells of patients with and without endometriosis. Results are presented as the mean+SEM. M: menstrual phase, P: proliferative phase, S: secretory phase. Endo (+): Endometrium of patients with endometriosis (M: n = 4, P: n = 8, S: n = 8). Endo (–): endometrium of patients without endometriosis (M: n = 4, P: n = 5, S: n = 5). a: p<.05 versus PKF 115–584–treated endometrial epithelial or stromal cells of patients without endometriosis.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosis

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

openalex
last seen: 2026-05-11T08:34:21.999627+00:00
License: CC0 · commercial use OK